BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+4.42%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.14B
AUM Growth
+$1.14B
Cap. Flow
+$131M
Cap. Flow %
11.49%
Top 10 Hldgs %
48.07%
Holding
60
New
9
Increased
13
Reduced
15
Closed
3

Top Buys

1
FPRX
Five Prime Therapeutics, Inc.
FPRX
$31.3M
2
ARRY
Array Biopharma Inc
ARRY
$24.6M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$17.6M
4
ACIU icon
AC Immune
ACIU
$16.1M
5
REPL icon
Replimune Group
REPL
$14.7M

Top Sells

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
$11.6M
2
ARQL
Arqule Inc
ARQL
$9.17M
3
ANAB icon
AnaptysBio
ANAB
$8.48M
4
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.91M
5
FBRX icon
Forte Biosciences
FBRX
$4.4M

Sector Composition

1 Healthcare 84.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XENE icon
26
Xenon Pharmaceuticals
XENE
$3B
$15.4M 1.35%
1,165,553
+444,723
+62% +$5.87M
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
$15M 1.32%
2,787,629
+2,099,000
+305% +$11.3M
CTIC
28
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$15M 1.32%
6,929,690
– –
RCUS icon
29
Arcus Biosciences
RCUS
$1.21B
$14.8M 1.3%
1,058,840
+99,000
+10% +$1.38M
REPL icon
30
Replimune Group
REPL
$458M
$14.7M 1.29%
+911,852
New +$14.7M
VSTM icon
31
Verastem
VSTM
$561M
$14.4M 1.27%
1,986,994
-255,359
-11% -$1.85M
KALV icon
32
KalVista Pharmaceuticals
KALV
$729M
$13.5M 1.18%
+609,014
New +$13.5M
CALA
33
DELISTED
Calithera Biosciences, Inc
CALA
$13.4M 1.17%
+2,544,000
New +$13.4M
MEIP icon
34
MEI Pharma
MEIP
$150M
$13.3M 1.17%
3,080,308
– –
FSTX
35
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$11.5M 1.01%
953,301
+167,351
+21% +$2.02M
SNDX icon
36
Syndax Pharmaceuticals
SNDX
$1.37B
$9.97M 0.88%
1,233,618
– –
OMED
37
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$8.57M 0.75%
4,042,989
-56,600
-1% -$120K
CDTX icon
38
Cidara Therapeutics
CDTX
$1.59B
$8.5M 0.75%
1,930,670
– –
VBIV
39
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$7.5M 0.66%
3,100,000
– –
ALBO
40
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$7.21M 0.63%
218,800
-1,200
-0.5% -$39.6K
CFRX
41
DELISTED
ContraFect Corporation
CFRX
$7.2M 0.63%
3,478,326
+117,255
+3% +$243K
PRNB
42
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$7.01M 0.62%
+240,000
New +$7.01M
MACK
43
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$5.92M 0.52%
1,110,588
– –
ARGX icon
44
argenx
ARGX
$43.4B
$5.83M 0.51%
+76,808
New +$5.83M
TSRO
45
DELISTED
TESARO, Inc.
TSRO
$5.46M 0.48%
+140,000
New +$5.46M
PHXM
46
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$5.45M 0.48%
625,000
– –
GNCA
47
DELISTED
Genocea Biosciences, Inc.
GNCA
$4.11M 0.36%
5,265,000
– –
ALPN
48
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.07M 0.36%
643,059
– –
SURF
49
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$3.94M 0.35%
360,218
+25,885
+8% +$283K
VIRX
50
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.37M 0.3%
1,684,636
– –
1
2
3